B
Beijing SL Pharmaceutical Co Ltd
SZSE:002038
Beijing SL Pharmaceutical Co Ltd
SZSE:002038
Price:
8.62 CNY
0.12%
Market Closed
Updated:
May 2, 2024
Income Statement
Earnings Waterfall
Beijing SL Pharmaceutical Co Ltd
Beijing SL Pharmaceutical Co Ltd
|
Revenue
|
999.8m
CNY
|
|
Cost of Revenue
|
-187.7m
CNY
|
|
Gross Profit
|
812.1m
CNY
|
|
Operating Expenses
|
-639.5m
CNY
|
|
Operating Income
|
172.7m
CNY
|
|
Other Expenses
|
141.4m
CNY
|
|
Net Income
|
314m
CNY
|
Income Statement
Beijing SL Pharmaceutical Co Ltd
Beijing SL Pharmaceutical Co Ltd
Currency: CNY
| Sep-2013 | Dec-2013 | Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||||||||||||||||||||||||
| Revenue |
1 201
N/A
|
1 162
-3%
|
1 219
+5%
|
1 204
-1%
|
1 229
+2%
|
1 243
+1%
|
1 232
-1%
|
1 195
-3%
|
1 169
-2%
|
1 157
-1%
|
1 138
-2%
|
1 090
-4%
|
1 032
-5%
|
1 010
-2%
|
977
-3%
|
1 004
+3%
|
1 085
+8%
|
1 242
+14%
|
1 456
+17%
|
1 757
+21%
|
2 019
+15%
|
2 168
+7%
|
2 193
+1%
|
2 237
+2%
|
2 192
-2%
|
2 030
-7%
|
1 759
-13%
|
1 517
-14%
|
1 296
-15%
|
1 113
-14%
|
1 171
+5%
|
1 200
+2%
|
1 184
-1%
|
1 215
+3%
|
1 237
+2%
|
1 144
-7%
|
1 128
-1%
|
1 050
-7%
|
1 072
+2%
|
1 079
+1%
|
1 000
-7%
|
|
| Gross Profit | ||||||||||||||||||||||||||||||||||||||||||
| Cost of Revenue |
(416)
|
(379)
|
(406)
|
(377)
|
(379)
|
(373)
|
(376)
|
(378)
|
(375)
|
(394)
|
(405)
|
(386)
|
(368)
|
(351)
|
(361)
|
(375)
|
(347)
|
(364)
|
(388)
|
(412)
|
(465)
|
(448)
|
(486)
|
(523)
|
(534)
|
(417)
|
(389)
|
(314)
|
(252)
|
(163)
|
(182)
|
(190)
|
(187)
|
(184)
|
(211)
|
(183)
|
(184)
|
(157)
|
(160)
|
(178)
|
(188)
|
|
| Gross Profit |
785
N/A
|
783
0%
|
813
+4%
|
828
+2%
|
850
+3%
|
870
+2%
|
856
-2%
|
817
-5%
|
794
-3%
|
763
-4%
|
734
-4%
|
704
-4%
|
664
-6%
|
659
-1%
|
617
-6%
|
629
+2%
|
738
+17%
|
878
+19%
|
1 068
+22%
|
1 345
+26%
|
1 555
+16%
|
1 719
+11%
|
1 707
-1%
|
1 714
+0%
|
1 659
-3%
|
1 612
-3%
|
1 370
-15%
|
1 202
-12%
|
1 045
-13%
|
949
-9%
|
989
+4%
|
1 010
+2%
|
997
-1%
|
1 031
+3%
|
1 025
-1%
|
962
-6%
|
944
-2%
|
893
-5%
|
912
+2%
|
901
-1%
|
812
-10%
|
|
| Operating Income | ||||||||||||||||||||||||||||||||||||||||||
| Operating Expenses |
(183)
|
(179)
|
(170)
|
(153)
|
(163)
|
(158)
|
(142)
|
(152)
|
(140)
|
(184)
|
(184)
|
(187)
|
(204)
|
(203)
|
(206)
|
(238)
|
(322)
|
(497)
|
(600)
|
(788)
|
(930)
|
(1 059)
|
(1 047)
|
(1 063)
|
(1 070)
|
(1 124)
|
(1 017)
|
(1 002)
|
(915)
|
(786)
|
(811)
|
(777)
|
(764)
|
(803)
|
(790)
|
(752)
|
(761)
|
(743)
|
(733)
|
(685)
|
(639)
|
|
| Selling, General & Administrative |
(180)
|
(84)
|
(166)
|
(147)
|
(157)
|
(93)
|
(135)
|
(143)
|
(135)
|
(88)
|
(172)
|
(177)
|
(195)
|
(142)
|
(201)
|
(234)
|
(315)
|
(418)
|
(604)
|
(792)
|
(916)
|
(975)
|
(997)
|
(1 042)
|
(1 043)
|
(972)
|
(922)
|
(853)
|
(772)
|
(556)
|
(620)
|
(558)
|
(548)
|
(561)
|
(623)
|
(607)
|
(598)
|
(513)
|
(577)
|
(530)
|
(479)
|
|
| Research & Development |
0
|
(88)
|
0
|
0
|
0
|
(59)
|
0
|
0
|
0
|
(92)
|
0
|
0
|
0
|
(55)
|
0
|
0
|
0
|
(74)
|
0
|
0
|
(19)
|
(67)
|
(62)
|
(85)
|
(103)
|
(122)
|
(134)
|
(141)
|
(125)
|
(181)
|
(206)
|
(236)
|
(231)
|
(185)
|
(188)
|
(155)
|
(172)
|
(151)
|
(159)
|
(159)
|
(166)
|
|
| Depreciation & Amortization |
0
|
(7)
|
0
|
0
|
0
|
(7)
|
0
|
0
|
0
|
(7)
|
0
|
0
|
0
|
(7)
|
0
|
0
|
0
|
(13)
|
0
|
0
|
0
|
(38)
|
0
|
0
|
0
|
(59)
|
0
|
0
|
0
|
(62)
|
0
|
0
|
0
|
(73)
|
0
|
0
|
0
|
(86)
|
0
|
0
|
0
|
|
| Other Operating Expenses |
(2)
|
(0)
|
(4)
|
(6)
|
(6)
|
(0)
|
(7)
|
(8)
|
(4)
|
4
|
(13)
|
(10)
|
(10)
|
1
|
(5)
|
(4)
|
(7)
|
8
|
5
|
4
|
5
|
20
|
11
|
64
|
76
|
29
|
39
|
(9)
|
(19)
|
13
|
15
|
17
|
15
|
16
|
20
|
10
|
10
|
6
|
4
|
3
|
6
|
|
| Operating Income |
602
N/A
|
603
+0%
|
643
+7%
|
675
+5%
|
687
+2%
|
712
+4%
|
714
+0%
|
665
-7%
|
654
-2%
|
579
-12%
|
549
-5%
|
517
-6%
|
460
-11%
|
455
-1%
|
411
-10%
|
391
-5%
|
417
+7%
|
381
-8%
|
468
+23%
|
557
+19%
|
625
+12%
|
660
+6%
|
659
0%
|
651
-1%
|
589
-10%
|
488
-17%
|
353
-28%
|
200
-43%
|
130
-35%
|
163
+26%
|
177
+9%
|
233
+31%
|
233
+0%
|
229
-2%
|
235
+3%
|
210
-11%
|
183
-13%
|
150
-18%
|
179
+20%
|
217
+21%
|
173
-20%
|
|
| Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
| Interest Income Expense |
42
|
44
|
56
|
56
|
62
|
68
|
82
|
99
|
88
|
78
|
39
|
13
|
22
|
54
|
70
|
85
|
118
|
136
|
223
|
212
|
166
|
22
|
39
|
33
|
55
|
73
|
50
|
181
|
212
|
250
|
274
|
293
|
310
|
226
|
183
|
82
|
45
|
108
|
249
|
224
|
185
|
|
| Non-Reccuring Items |
0
|
7
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(3)
|
0
|
0
|
0
|
104
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
3
|
0
|
3
|
0
|
5
|
0
|
0
|
0
|
|
| Gain/Loss on Disposition of Assets |
0
|
(0)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
18
|
19
|
20
|
19
|
31
|
32
|
26
|
24
|
16
|
12
|
15
|
11
|
10
|
20
|
20
|
25
|
22
|
1
|
(3)
|
(10)
|
(11)
|
(10)
|
(10)
|
(10)
|
(10)
|
0
|
0
|
(0)
|
0
|
(0)
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
(4)
|
(4)
|
(4)
|
(4)
|
|
| Pre-Tax Income |
662
N/A
|
674
+2%
|
718
+7%
|
750
+4%
|
780
+4%
|
812
+4%
|
821
+1%
|
787
-4%
|
758
-4%
|
669
-12%
|
603
-10%
|
541
-10%
|
492
-9%
|
527
+7%
|
501
-5%
|
500
0%
|
557
+11%
|
623
+12%
|
688
+11%
|
759
+10%
|
780
+3%
|
672
-14%
|
688
+3%
|
674
-2%
|
634
-6%
|
561
-11%
|
402
-28%
|
381
-5%
|
342
-10%
|
413
+21%
|
451
+9%
|
525
+16%
|
546
+4%
|
458
-16%
|
419
-8%
|
296
-29%
|
229
-22%
|
259
+13%
|
424
+64%
|
437
+3%
|
354
-19%
|
|
| Net Income | ||||||||||||||||||||||||||||||||||||||||||
| Tax Provision |
(95)
|
(102)
|
(106)
|
(107)
|
(113)
|
(111)
|
(110)
|
(116)
|
(100)
|
(92)
|
(85)
|
(70)
|
(77)
|
(80)
|
(76)
|
(74)
|
(81)
|
(94)
|
(103)
|
(112)
|
(107)
|
(108)
|
(108)
|
(107)
|
(103)
|
(81)
|
(61)
|
(58)
|
(56)
|
(51)
|
(60)
|
(61)
|
(54)
|
(37)
|
(25)
|
(9)
|
(6)
|
(31)
|
(57)
|
(55)
|
(44)
|
|
| Income from Continuing Operations |
566
|
572
|
612
|
643
|
667
|
701
|
711
|
671
|
658
|
577
|
519
|
470
|
415
|
447
|
424
|
426
|
476
|
529
|
585
|
647
|
673
|
563
|
581
|
567
|
531
|
480
|
341
|
323
|
286
|
362
|
391
|
464
|
492
|
421
|
394
|
287
|
224
|
228
|
368
|
381
|
310
|
|
| Income to Minority Interest |
6
|
5
|
5
|
0
|
1
|
(6)
|
(6)
|
(5)
|
(5)
|
(2)
|
(1)
|
2
|
1
|
5
|
6
|
5
|
10
|
5
|
4
|
4
|
2
|
8
|
9
|
11
|
12
|
7
|
6
|
3
|
1
|
3
|
4
|
5
|
6
|
5
|
3
|
3
|
4
|
6
|
5
|
5
|
4
|
|
| Net Income (Common) |
572
N/A
|
577
+1%
|
617
+7%
|
643
+4%
|
668
+4%
|
695
+4%
|
705
+1%
|
667
-5%
|
653
-2%
|
575
-12%
|
518
-10%
|
472
-9%
|
416
-12%
|
452
+9%
|
430
-5%
|
431
+0%
|
486
+13%
|
534
+10%
|
589
+10%
|
651
+11%
|
675
+4%
|
571
-15%
|
590
+3%
|
578
-2%
|
543
-6%
|
487
-10%
|
348
-29%
|
327
-6%
|
287
-12%
|
365
+27%
|
395
+8%
|
470
+19%
|
497
+6%
|
426
-14%
|
397
-7%
|
290
-27%
|
228
-21%
|
234
+3%
|
373
+59%
|
386
+4%
|
314
-19%
|
|
| EPS (Diluted) |
0.56
N/A
|
0.56
N/A
|
0.59
+5%
|
0.61
+3%
|
0.64
+5%
|
0.69
+8%
|
0.69
N/A
|
0.66
-4%
|
0.65
-2%
|
0.56
-14%
|
0.52
-7%
|
0.47
-10%
|
0.41
-13%
|
0.44
+7%
|
0.41
-7%
|
0.41
N/A
|
0.46
+12%
|
0.52
+13%
|
0.57
+10%
|
0.63
+11%
|
0.66
+5%
|
0.56
-15%
|
0.58
+4%
|
0.57
-2%
|
0.53
-7%
|
0.47
-11%
|
0.33
-30%
|
0.31
-6%
|
0.27
-13%
|
0.36
+33%
|
0.38
+6%
|
0.45
+18%
|
0.48
+7%
|
0.41
-15%
|
0.39
-5%
|
0.28
-28%
|
0.22
-21%
|
0.23
+5%
|
0.36
+57%
|
0.38
+6%
|
0.31
-18%
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
